NZ513739A - Cloning of cDNA of mage's 5, 8, 9 and 11 and their uses in diagnosis of cancer - Google Patents
Cloning of cDNA of mage's 5, 8, 9 and 11 and their uses in diagnosis of cancerInfo
- Publication number
- NZ513739A NZ513739A NZ513739A NZ51373900A NZ513739A NZ 513739 A NZ513739 A NZ 513739A NZ 513739 A NZ513739 A NZ 513739A NZ 51373900 A NZ51373900 A NZ 51373900A NZ 513739 A NZ513739 A NZ 513739A
- Authority
- NZ
- New Zealand
- Prior art keywords
- mage
- cdna
- cloning
- diagnosis
- cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26097899A | 1999-03-02 | 1999-03-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ513739A true NZ513739A (en) | 2001-09-28 |
Family
ID=22991462
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ513739A NZ513739A (en) | 1999-03-02 | 2000-03-01 | Cloning of cDNA of mage's 5, 8, 9 and 11 and their uses in diagnosis of cancer |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1194542A1 (en) |
JP (1) | JP2003512814A (en) |
KR (1) | KR20020011967A (en) |
AU (1) | AU3389500A (en) |
CA (1) | CA2366059A1 (en) |
NZ (1) | NZ513739A (en) |
WO (1) | WO2000052163A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007053956A1 (en) | 2005-11-14 | 2007-05-18 | Universite Laval | Cancer antigen mage-a9 and uses thereof |
SG11201913302SA (en) | 2017-07-07 | 2020-01-30 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against lung cancer, including nsclc, sclc and other cancers |
US10800823B2 (en) | 2017-07-07 | 2020-10-13 | Immatics Biotechnologies Gmbh | Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers |
FR3087448B1 (en) | 2018-10-23 | 2023-10-13 | Pdc Line Pharma | PDC LINE MODIFIED TO SECRET A CYTOKINE |
TW202039535A (en) | 2018-12-18 | 2020-11-01 | 德商英麥提克生物技術股份有限公司 | Immunotherapy with b*08 restricted peptides and combination of peptides against cancers and related methods |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5612201A (en) * | 1991-05-23 | 1997-03-18 | Ludwig Institute For Cancer Research | Isolated nucleic acid molecules useful in determining expression of a tumor rejection antigen precursor |
US5342774A (en) * | 1991-05-23 | 1994-08-30 | Ludwig Institute For Cancer Research | Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1 |
-
2000
- 2000-03-01 EP EP00912112A patent/EP1194542A1/en not_active Withdrawn
- 2000-03-01 NZ NZ513739A patent/NZ513739A/en not_active Application Discontinuation
- 2000-03-01 WO PCT/US2000/005346 patent/WO2000052163A1/en not_active Application Discontinuation
- 2000-03-01 KR KR1020017011090A patent/KR20020011967A/en not_active Application Discontinuation
- 2000-03-01 JP JP2000602775A patent/JP2003512814A/en active Pending
- 2000-03-01 CA CA002366059A patent/CA2366059A1/en not_active Abandoned
- 2000-03-01 AU AU33895/00A patent/AU3389500A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
KR20020011967A (en) | 2002-02-09 |
AU3389500A (en) | 2000-09-21 |
WO2000052163A1 (en) | 2000-09-08 |
CA2366059A1 (en) | 2000-09-08 |
EP1194542A1 (en) | 2002-04-10 |
JP2003512814A (en) | 2003-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1042084A1 (en) | Substituted benzimidazoles and their preparation and use. | |
ZA200007040B (en) | Catalyst modifiers and their use in the polymerization of olefin(s). | |
EP1076090A2 (en) | ESTs and encoded human proteins | |
MXPA02004770A (en) | Therapeutic compositions and methods of use thereof. | |
GB9903841D0 (en) | Diagnosis and treatment of cancer | |
GB0106183D0 (en) | Improvements in or relating to the treatment of lesions | |
PL353246A1 (en) | Compositions for the treatment and diagnosis of breast cancer and methods for their use | |
WO1999029729A3 (en) | Antagonists of neuropilin receptor function and use thereof | |
PL352330A1 (en) | Derivatives of pyridopyranoazepine, making of same and use of same in therapy | |
IL206604A (en) | Transmembrane protein, 24p4c12, expressed in prostate cancer, immunogenic compositions comprising them and uses thereof | |
AU2001250978A1 (en) | Polynucleotides and polypeptides, their use in diagnosis and treatment of cardiac, renal or inflammary disease | |
HK1031725A1 (en) | 3-amino-3-arylpropan-1-ol-derivates, their preparation and their use | |
HUP0202048A2 (en) | Use of alpha1betha1 integrin receptor inhibitors and tgf-betha1 inhibitors in the treatment of kidney disease | |
ZA97741B (en) | Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders. | |
HK1063629A1 (en) | 3,7-Diazabicyclo Ä3.3.0Üoctanes and their use in the treatment of cardiac arrhythmias | |
EP1210416A4 (en) | Novel genes encoding proteins having diagnostic, preventive, therapeutic, and other uses | |
EP1208191A4 (en) | 13 human colon and colon cancer associated proteins | |
HUP0201997A3 (en) | Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications | |
IL160018A0 (en) | Isoxazolopyridinones and use thereof in the treatment of parkinson's disease | |
HUP0003811A2 (en) | Oxyranyle-triazoline thiones, their preparation and their use as microbicides | |
HK1042504A1 (en) | Human cervical cancer 1 protooncogene and protein encoded therein | |
ZA200006518B (en) | Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics. | |
NZ513739A (en) | Cloning of cDNA of mage's 5, 8, 9 and 11 and their uses in diagnosis of cancer | |
AU5618700A (en) | Extracellular camp-dependent protein kinase in diagnosis, prognosis and treatment of cancer | |
AU6111800A (en) | 26 human prostate and prostate cancer associated proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AVOD | Application void |